Evidence map›Paper›PMID 35938513›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2023

Long-term effects of Pfizer-BioNTech COVID-19 vaccinations on platelets.

Yuqi Zhou, Masako Nishikawa, Hiroshi Kanno, Ruoxi Yang, Yuma Ibayashi, Ting-Hui Xiao, Walker Peterson, Maik Herbig, Nao Nitta, Shigeki Miyata and 5 more

Abstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Real-time intelligent classification of COVID-19 and thrombosis via massive image-based analysis of platelet aggregates.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023
    Article
  6. Article
  7. Article
  8. Long-term effects of Pfizer-BioNTech COVID-19 vaccinations on platelets.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023
    Article
  9. Review
  10. Article
  11. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Yuqi ZhouDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-1206-0049
Masako NishikawaDepartment of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Hiroshi KannoDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.
Ruoxi YangDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.
Yuma IbayashiDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.
Ting-Hui XiaoDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-7339-152X
Walker PetersonDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.
Maik HerbigDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-7592-7829
Nao NittaCYBO, Inc, Tokyo, Japan.
Shigeki MiyataResearch and Development Department, Central Blood Institute, Japanese Red Cross Society, Tokyo, Japan.
Yogendra KanthiNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-5660-5194
Gustavo K RohdeDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
Kyoji MoriyaDepartment of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan.
Yutaka YatomiDepartment of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Keisuke GodaDepartment of Chemistry, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-6302-6038

Funding

Human Translational Studies of Vascular Thrombosis and InflammationZIAHL006262 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KANTHI, YOGENDRA · 2021 to 2025
$4.7M
Vascular Immunobiology Mechanistic and Translational StudiesZIAHL006267 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KANTHI, YOGENDRA · 2021 to 2025
$4.6M
Unraveling Cytotoxic and Thrombotic Signals in Host-defense ResponsesZIAHL006263 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KANTHI, YOGENDRA · 2021 to 2025
$3.5M
Transport transforms for biomedical data modeling, estimation, and classificationR01GM130825 · NIGMS · UNIVERSITY OF VIRGINIA · PI Gustavo Kunde Rohde · 2019 to 2026
$2.8M
Intramural NIH HHS Z99 HL999999Intramural NIH HHS ZIA HL006262Intramural NIH HHS ZIA HL006263Intramural NIH HHS ZIA HL006267NIGMS NIH HHS R01 GM130825
6 · The paper itself

Abstract

There is a global concern about the safety of COVID-19 vaccines associated with platelet function. However, their long-term effects on overall platelet activity remain poorly understood. Here we address this problem by image-based single-cell profiling and temporal monitoring of circulating platelet aggregates in the blood of healthy human subjects, before and after they received multiple Pfizer-BioNTech (BNT162b2) vaccine doses over a time span of nearly 1 year. Results show no significant or persisting platelet aggregation trends following the vaccine doses, indicating that any effects of vaccinations on platelet turnover, platelet activation, platelet aggregation, and platelet-leukocyte interaction was insignificant.

Indexed as

COVID-19COVID-19 VaccinesBlood PlateletsBNT162 VaccineHumansVaccinationBNT162 VaccineCOVID-19 VaccinesCOVID-19mRNA vaccineplatelet aggregationthrombosis

Identifiers

PMID35938513
PMCPMC9538905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.